FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1465731000168103: Laceraine Topical Wound Anaesthetic (epinephrine acid tartrate 1.8 mg / 1 mL + lidocaine hydrochloride 40 mg / 1 mL + tetracaine hydrochloride 5 mg / 1 mL) solution, 5 mL vial (trade product unit of use)

    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    4391881000168114 Laceraine Topical Wound Anaesthetic (epinephrine acid tartrate 1.8 mg / 1 mL + lidocaine hydrochloride 40 mg / 1 mL + tetracaine hydrochloride 5 mg / 1 mL) solution, 5 mL vial (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
    4391891000168112 Laceraine Topical Wound Anaesthetic solution, 5 mL vial en Synonym Active Case sensitive Australian Medicines Terminology module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial Is a Laceraine Topical Wound Anaesthetic false Inferred relationship Some
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial Is a lidocaine (lignocaine) hydrochloride 4% + tetracaine (amethocaine) hydrochloride 0.5% + adrenaline (epinephrine) acid tartrate 0.18% solution, 5 mL vial false Inferred relationship Some
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial Is a trade product unit of use false Inferred relationship Some
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial has manufactured dose form solution false Inferred relationship Some
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial has intended active ingredient lidocaine false Inferred relationship Some 667192543
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial has Australian BoSS lidocaine hydrochloride false Inferred relationship Some 667192543
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial has intended active ingredient tetracaine (amethocaine) false Inferred relationship Some 2050670680
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial has Australian BoSS tetracaine hydrochloride (AU substance) false Inferred relationship Some 2050670680
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial has unit of use vial false Inferred relationship Some 2083164726
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial has intended active ingredient adrenaline (epinephrine) false Inferred relationship Some 1816901842
    Laceraine Topical Wound Anaesthetic solution, 5 mL vial has Australian BoSS adrenaline (epinephrine) acid tartrate false Inferred relationship Some 1816901842
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Laceraine Topical Wound Anaesthetic solution, 5 x 5 mL vials has TPUU False Laceraine Topical Wound Anaesthetic solution, 5 mL vial Inferred relationship Some 186537123
    Laceraine Topical Wound Anaesthetic solution, 5 x 5 mL vials has TPUU False Laceraine Topical Wound Anaesthetic solution, 5 mL vial Inferred relationship Some 1901558245

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start